Bupivacaine Liposomal Injectable Suspension, Pain and Narcotic Use After Elective Orthognathic Surgery
Status:
Withdrawn
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This research is being done to determine quantitative and qualitative differences in
patients' post-operative pain levels following elective orthognathic surgery after the local
administration of a liposomal bupivacaine injection.
A primary objective is to determine whether using a liposomal bupivacaine injection placed
locally at the conclusion of elective orthognathic surgery will decrease pain levels (as
determined by VAS scores). A secondary objective is to examine whether using a long acting
liposomal bupivacaine injection locally at the conclusion of elective orthognathic surgery
leads to decreased use of narcotics post-operatively.